Atlas Trials

Oscotec Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Oscotec Inc.

RecordFirmDate
Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions (NCT07675226)Oscotec Inc.2026-07-10
Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors (NCT07358806)Oscotec Inc.2025-12-18
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors (NCT05971862)Oscotec Inc.2022-01-25
A Study of the Absorption, Metabolism, and Excretion of [14C]-SKI-O-703 Following a Single Oral Dose in Healthy Male Subjects (NCT05042986)Oscotec Inc.2021-08-10
Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP) (NCT04056195)Oscotec Inc.2019-10-11
A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies. (NCT04057118)Oscotec Inc.2019-03-20
Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML) (NCT03564288)Oscotec Inc.2018-02-23

Track Oscotec Inc. automatically

Every clearance here is in the API, with alerts when new ones post.